Metraipolis › archive › dc_beb3db937495

N-(2-Hydroxyphenyl)-2-propylpentanamide Modulates HDAC1 and GPER1 Expression in a Rodent Model of Triple-Negative Breast Cancer — Europe PMC PMID:41751221

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41751221
DOI
10.3390/biomedicines14020322
License (as archived)
solo-consultazione
Archived
2026-11-06T09:56:09.019Z
SHA-256 of the archived text
c12071bce7c3593c28864c2503968e37b85ba553ecabad057adc199d06e30667
Stable URL of this page
https://metraipolis.com/documento/dc_beb3db937495

How to cite

N-(2-Hydroxyphenyl)-2-propylpentanamide Modulates HDAC1 and GPER1 Expression in a Rodent Model of Triple-Negative Breast Cancer — Europe PMC PMID:41751221 — Europe PMC (en), https://europepmc.org/article/MED/41751221 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_beb3db937495 (Metraipolis archive dc_beb3db937495, sha256 c12071bce7c3593c28864c2503968e37b85ba553ecabad057adc199d06e30667)
BibTeX
@misc{dcbeb3db937495,
  title = {N-(2-Hydroxyphenyl)-2-propylpentanamide Modulates HDAC1 and GPER1 Expression in a Rodent Model of Triple-Negative Breast Cancer — Europe PMC PMID:41751221},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41751221},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_beb3db937495; sha256 c12071bce7c3593c28864c2503968e37b85ba553ecabad057adc199d06e30667},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41751221. Agents can read the archived copy with the MCP tool read_document.